BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31925572)

  • 21. Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts.
    Camp J; Filla T; Glaubitz L; Kaasch AJ; Fuchs F; Scarborough M; Kim HB; Tilley R; Liao CH; Edgeworth J; Nsutebu E; López-Cortés LE; Morata L; Llewelyn MJ; Fowler VG; Thwaites G; Seifert H; Kern WV; Rieg S; ;
    Clin Microbiol Infect; 2022 Aug; 28(8):1149.e1-1149.e9. PubMed ID: 35339677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
    Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.
    Kang CI; Song JH; Ko KS; Chung DR; Peck KR;
    Support Care Cancer; 2012 Mar; 20(3):483-8. PubMed ID: 21318576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study.
    Chihara S; Popovich KJ; Weinstein RA; Hota B
    BMC Infect Dis; 2010 Jul; 10():225. PubMed ID: 20667139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
    Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
    Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
    Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
    Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential impacts of inappropriate empirical therapy on ED patients with Staphylococcus aureus and streptococci bacteremia.
    Lee CH; Yang CY; Hsieh CC; Hong MY; Lee CC
    Am J Emerg Med; 2020 May; 38(5):940-946. PubMed ID: 31493980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
    Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
    Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staphylococcus aureus septicemia in non-neutropenic adult patients hospitalized in internal medicine units.
    Gallucci F; Amato G; Esposito P; Belli CM; Russo R; Uomo G
    Rocz Akad Med Bialymst; 2005; 50():216-9. PubMed ID: 16358970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecthyma gangrenosum caused by Staphylococcus aureus in hematological malignancies: Case reports and literature review.
    Kudo Nagata Y; Sekiya N; Fukushima K; Horiuchi M; Doki N
    Medicine (Baltimore); 2022 Aug; 101(33):e30070. PubMed ID: 35984202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection.
    Guimaraes AO; Cao Y; Hong K; Mayba O; Peck MC; Gutierrez J; Ruffin F; Carrasco-Triguero M; Dinoso JB; Clemenzi-Allen A; Koss CA; Maskarinec SA; Chambers HF; Fowler VG; Baruch A; Rosenberger CM
    Clin Infect Dis; 2019 Apr; 68(9):1502-1511. PubMed ID: 30165412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
    Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
    Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
    BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
    Oh DH; Kim JJ; Kim J; Seong H; Lee SJ; Kim YC; Kim EJ; Jung IY; Jeong WY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    BMC Infect Dis; 2018 Jan; 18(1):60. PubMed ID: 29378565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
    Chaftari AM; Hachem R; Jordan M; Garoge K; Al Hamal Z; El Zakhem A; Viola GM; Granwehr B; Mulanovich V; Gagel A; Reitzel R; Yousif A; Jiang Y; Raad I
    Antimicrob Agents Chemother; 2016 Jan; 60(1):239-44. PubMed ID: 26482312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain.
    Bader MS
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1219-25. PubMed ID: 17080380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.